Presentation
Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation
World Congress on Parkinson’s Disease and Related Disorders
(2009)
Abstract
This presentation was given at the World Congress on Parkinson’s Disease and Related Disorders.
Keywords
- Long-term effect,
- Varenicline,
- Chantix,
- Ataxic patients,
- Prolonged symptomatic benefit,
- Drug discontinuation
Disciplines
Publication Date
December 13, 2009
Location
Miami Beach, FL
Citation Information
Theresa A. Zesiewicz, Kelly L. Sullivan, A. Miller, L. E. Dempsey, et al.. "Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation" World Congress on Parkinson’s Disease and Related Disorders (2009) Available at: http://works.bepress.com/kelly_sullivan/161/